Best practices in molecular testing and targeted therapy for HR+/HER2- metastatic breast cancer

March 21, 2025 00:26:13

Show Notes

This podcast explores the best practices in molecular testing and targeted therapy for HR+/HER2- metastatic breast cancer.  

Dr Rena Callahan and Dr Roberto Salgado discuss key biomarkers, testing methods, and clinical decision-making, offering expert insights on how to optimise precision medicine.  

Topics include liquid vs. tumour biopsy, single gene vs. broad panel testing, and regional differences in testing practices.  

Tune in for a practical, expert-led discussion on how molecular testing can guide personalised treatment and improve patient outcomes. 

 

Key clinical takeaways: 

 

You can also watch a video of the experts in conversation and download the accompanying transcript on our website: https://cor2ed.com/precision-oncology-connect/programmes/molecular-testing-targeted-therapy-metastatic-breast-cancer/?media=0

Or watch on YouTube: https://www.youtube.com/watch?v=CTnXmh1oDwQ

Follow us on social media: 

LinkedIn: https://www.linkedin.com/company/ntrk-connect/  

X: https://x.com/PresOnc_Connect  

This content is intended for healthcare professionals only. 

The medical experts in this podcast are expressing their own views and not those of COR2ED, Supporters or their institution.  This podcast is supported by an Independent Education Grant from Thermo Fisher Scientific. 

This podcast is developed by cor2ed.com 

Published March 2025 

Subscribe to this channel to stay up to date with new Independent Education programmes as they’re released. 

Other Episodes

Episode

April 25, 2024 00:29:54
Episode Cover

Câncer de Próstata: Desafios da Fase Pré-Analítica e Teste de Biomarcadores

Quais são os desafios mais comuns na fase pré-analítica na luta contra o câncer de próstata e como podemos superá-los? Qual a importância de...

Listen

Episode

February 17, 2025 00:11:28
Episode Cover

Advanced or recurrent endometrial cancer: Molecular classification and treatment decisions

Advanced or recurrent endometrial cancer: Molecular classification and treatment decisions   Key clinical takeaways:   MMR status should be tested in all patients at diagnosis and...

Listen

Episode

May 28, 2024 00:21:47
Episode Cover

Regional differences in NET: Epidemiology, diagnosis, and referral strategies

In this first episode of a two-part podcast series, Prof. Martyn Caplin and Prof. Rachel Riechelmann discuss regional differences in NET epidemiology, and patient...

Listen